Top Markets
Coin of the day
PT Indofarma Tbk PT Indofarma Tbk

PT Indofarma Tbk

INAF
Rang in Aktien #29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Aktienkurs
$0.00748841
Zuletzt synchronisiert: 2024-07-01
Marktkapitalisierung
$23.21M
Veränderung (1 Tag)
-2.83%
Veränderung (1 Jahr)
0.00%
Land
ID
Handel PT Indofarma Tbk (INAF)

Kategorie

Kursverlauf für PT Indofarma Tbk (INAF)
Höchster Schlusskurs: $0.01 am 2024-07-01

Niedrigster Schlusskurs: $0.02 am 2001-04-01
Kursverlauf der Aktie von PT Indofarma Tbk von 2001 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 -79.48%
2023 -40.10%
2022 -62.62%
2021 -42.63%
2020 548.81%
2019 -87.64%
2018 9.29%
2017 3.35%
2016 2,548.64%
2015 -56.24%
2014 104.51%
2013 -58.66%
2012 93.58%
2011 85.79%
2010 2.22%
2009 94.36%
2008 -80.00%
2007 109.18%
2006 -8.73%
2005 -29.01%
2004 -21.23%
2003 -24.45%
2002 47.86%
2001 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$164.10 26.95%
DE
$37.64 23.14%
JP
$222.33 32.79%
CH
$20.97 12.27%
IN